| Date | Title | Description |
| 16.09.2026 | Safer, Stronger, Built in America: President Trump’s Record in North Carolina | President Donald J. Trump returns to North Carolina today with a simple message: North Carolinians are better off with Republican leadership. Since taking office, the Trump Administration has driven crime down, put money back in workers’ po... |
| 15.09.2026 | AI Investment Frenzy Reshapes Global Tech Landscape | Tech giants ignite a global AI arms race. Google commits $15.1 billion to Finland's AI infrastructure, a European record. Hyperscalers like Microsoft, Amazon, Meta, and Oracle collectively invest nearly $800 billion this year, fueling a vas... |
| 15.09.2026 | U.S. politician makes super suspicious Google stock trade |
United States Representative Thomas Kean has disclosed another sale of Alphabet (NASDAQ: GOOGL) stock, adding to a growing pattern of exits from the technology giant.
The New Jersey Republican reported selling between $1,001 and $15,000 wo... |
| 28.08.2026 | Blood Clot Retrieval Devices Market to Reach USD 10.9 Billion by 2036 | Fact.MR projects the blood clot retrieval devices market to grow at a 15% CAGR from 2026 to 2036, driven by stroke care, minimally invasive procedures, and technology adoption.
The blood clot retrieval devices market is projected to reach U... |
| 26.08.2026 | Meta joins a list of corporations that have settled cases for billions of dollars | Getting your Trinity Audio player ready...
By MICHELLE CHAPMAN
Tech giant Meta this week agreed to pay $17 billion as part of a settlement to end a landmark trial related to safeguards for younger users of social media. It is one of the lar... |
| 20.08.2026 | Hair Loss & Growth Treatments and Products Market Latest Report 2026-2033 | Hair loss and growth treatments include pharmaceutical solutions, topical applications, dietary supplements, and advanced therapeutic products designed to prevent hair loss, stimulate hair regrowth, and improve hair health. The market addre... |
| 19.08.2026 | Российская фармкомпания стала лидером по выплатам врачам и медорганизациям | Российская фармкомпания стала лидером по выплатам врачам и медорганизациям Иностранные игроки все меньше тратят на исследования
«Р-Фарм» потратил на выплаты врачам и организациям в 2025 году 2,2 млрд руб., больше, чем любой другой член Ассо... |
| 18.08.2026 | Lytix Biopharma Strengthens Business Development Leadership with Appointment of Timothy Herpin as Chief Business Officer | Lytix Biopharma Strengthens Business Development Leadership with Appointment of Timothy Herpin as Chief Business Officer
Tue, Aug 18, 2026 10:35 CET Report this content
OSLO, Norway, 18 August 2026 – Lytix Biopharma ASA (“Lytix” or the “Com... |
| 18.08.2026 | Elicera Therapeutics appoints Johan Liwing as new CEO | Elicera Therapeutics appoints Johan Liwing as new CEO
Tue, Aug 18, 2026 08:30 CET Report this content
Gothenburg, August 18, 2026 – Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next generation ca... |
| 17.08.2026 | Eli Lilly and J&J bounce on new data, as software stocks give up last week’s gains | - |
| 17.08.2026 | Daily Stock Market Live
S&P 500 falls for a third day, as elevated global bond yields and oil prices weigh on market | The S&P 500 fell on Tuesday, pressured by a run in sovereign bond yields to multi-year highs amid concerns of persistent inflation and elevated oil prices. A pullback in semiconductor stocks also weighed on the broader market.
The broad... |
| 16.08.2026 | Here’s billionaire Ray Dalio’s updated stock portfolio |
Billionaire investor Ray Dalio’s hedge fund, Bridgewater Associates, has disclosed its latest stock holdings, revealing a portfolio valued at approximately $24.4 billion as of June 30, 2026.
The latest Form 13F filing shows that exchange-t... |
| 14.08.2026 | Pharmaceuticals Market Trends: Innovation, Rising Healthcare Demand, and Advanced Therapies Driving Growth | The pharmaceuticals market is witnessing strong growth as rising healthcare needs, increasing disease prevalence, expanding access to medicines, and continuous innovation in drug development drive global demand. Pharmaceutical products play... |
| 11.08.2026 | Quantified Named One of the Fastest-Growing AI & Data Companies on the Inc. 5000 List for the Second Consecutive Year | For the second consecutive year, Quantified lands on the Inc. 5000 list, fueled by growing adoption among top global pharma companies looking to keep commercial teams compliant, certified, coached, and ready to perform.
AUSTIN, Texas, Aug. ... |
| 07.08.2026 | A Cross Section of Company Statements Supporting Climate Action | Introduction
Over the past two years, the public conversation around corporate climate commitments has shifted considerably. Some companies that spoke openly about decarbonization have grown quieter, a phenomenon often described as “greenhu... |
| 07.08.2026 | Wellspect HealthCare Establishes Strategic Advisory Board and Appoints Paul Moraviec and Michael Frazzette | Wellspect HealthCare Establishes Strategic Advisory Board and Appoints Paul Moraviec and Michael Frazzette
Fri, Aug 07, 2026 17:35 CET Report this content
New Strategic Advisory Board supports Wellspect HealthCare’s next phase of growth, wi... |
| 07.08.2026 | По каким еще лекарствам приняла решение комиссия Минздрава | По каким еще лекарствам приняла решение комиссия Минздрава
Поддержано включение в перечень ЖНВЛП мосунетузумаба — инновационного онкогематологического препарата, применяемого у взрослых с рецидивирующей или рефрактерной фолликулярной лимфом... |
| 06.08.2026 |
Cramer’s lightning round: Buy Lockheed Martin | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Ameriprise Financial: “This thing is always... |
| 06.08.2026 |
Jim Cramer highlights 5 investing themes — and the stocks to buy for each | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer said earnings season reinforced five investing themes he thinks will produce the market’s best buying opportunities.
He highlighted stocks to buy for each theme, including Capital One, Ra... |
| 05.08.2026 | Icotyde Has Only 90 Days of Sales History When Cavanaugh Takes J&J’s Helm | By Benjamin Eddie
Published: Aug 05 2026, 12:52 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 04.08.2026 | Patti Scialfa Is in Remission: Multiple Myeloma Survival Has Risen Fivefold in 20 Years | By Jackie Manning
Published: Aug 04 2026, 8:46 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 03.08.2026 | Supernus and Indivior Combine to Build $2.2B CNS Biopharmaceutical Company | By Otis D. Sheehan
Published: Aug 03 2026, 11:10 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 31.07.2026 | AI Agents Invade Supply Chains: Freehand Lands $75M to Revolutionize Procurement | Freehand secured $75 million in new funding, led by Battery Ventures and NewRoad Capital Partners. This capital will scale its autonomous AI agents, revolutionizing enterprise supply chain and procurement. The technology directly tackles im... |
| 30.07.2026 | Markets Roil: AI Tech Falters, Oil Swings, Fed Holds Firm Amid Global Tensions | Markets reel from deep AI stock sell-offs this week. Major indexes saw mixed results, with oil prices volatile due to Mideast conflict. The Federal Reserve maintained interest rates, fueling market uncertainty. Corporations now question AI'... |
| 30.07.2026 | AI stocks rebound, and why J&J’s earnings guidance cut is not cause for concern | - |
| 29.07.2026 | Enterprise AI firm Freehand secures $75M led by Battery Ventures, NewRoad | Freehand, a San Francisco-headquartered enterprise AI company founded by Indian entrepreneurs, has raised $75 million in a funding round co-led by Battery Ventures, a global technology-focused investment firm, and NewRoad Capital Partners, ... |
| 29.07.2026 | Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 | ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced data to be presented this week at the 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro, Brazil. Multip... |
| 29.07.2026 | Moon Rabbit Appoints Amy Labb as Executive Vice President, Media | Industry leader to oversee integrated media practice and support agency's continued growth
NEW YORK, July 29, 2026 /PRNewswire-PRWeb/ -- Moon Rabbit, an award-winning independent advertising and media agency, today announced that Amy Labb h... |
| 28.07.2026 | Johnson & Johnson to pay nearly ₹52,700 crore after lawsuits linked baby powder to ovarian cancer | Johnson & Johnson and Kenvue Inc will pay around $5.5 billion ( ₹52,668 crore) to settle tens of thousands of lawsuits in the US that alleged the companies' baby powder and other talc products caused ovarian cancer.
J&J has maintain... |
| 28.07.2026 | Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight | Getting your Trinity Audio player ready...
By MICHELLE CHAPMAN, AP Business Writer
Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer.
The drugmaker, which ha... |
| 28.07.2026 | Johnson & Johnson announces US$5.5 billion settlement of talc lawsuits | NEW YORK: Johnson & Johnson said on Monday (Jul 27) it would pay US$5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark settlement aimed at closing a ... |
| 28.07.2026 | Stocks making the biggest moves premarket: Coca-Cola, Sherwin-Williams, Johnson & Johnson & more | - |
| 25.07.2026 | J&J Ottava FDA Clearance Breaks da Vinci’s Two-Decade Soft-Tissue Monopoly | By Brandon Fisher
Published: Jul 25 2026, 8:20 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 24.07.2026 | Pharmaceutical Frontier: Psychedelics Rise, GLP-1s Diversify, Global Innovation Thrives | The pharmaceutical industry undergoes rapid transformation. Big Pharma embraces psychedelic drugs, acquiring key innovators to treat diverse mental health conditions. This signals a new era for depression, PTSD, and anxiety therapies. Concu... |
| 24.07.2026 | Connecticut Innovations Generates Record $66.5 Million In Proceeds In FY2026 | Connecticut Innovations, the state’s strategic venture capital arm, announced a record fiscal year, generating $66.5 million in cash proceeds from a series of portfolio exits and a combined $76.1 million from all investment activities. Duri... |
| 23.07.2026 | NVIDIA Cuts Surgical Robot Training From Hours to Minutes With Open-Source Simulator | By Brandon Fisher
Published: Jul 23 2026, 6:32 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 22.07.2026 | J&J gets a big win on its new robotic surgical system — plus, a flood of earnings | - |
| 21.07.2026 |
Jim Cramer says this old-school investing concept still wins — even in the AI boom | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer urged investors to expand their portfolios beyond the market’s hottest AI winners.
“I’m not anti-tech. But I do like diversification,” the “Mad Money” host said.
CNBC’s Jim Cramer on Tues... |
| 19.07.2026 | The market for psychedelic drugs to treat mental health conditions gets a big buy signal | To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo
Thursday’s announcement that Eli Lilly will acquire AtaiBeckley, a clinical-stage maker of psychedelic drugs, for up to $3.8 billion indicates Big Pharma’s increasing embr... |
| 18.07.2026 | Global Markets Under Pressure: Tech Rout, Geopolitical Tensions Dominate | Global markets face renewed volatility. Tech stocks tumbled worldwide. Semiconductors led the decline. AI spending concerns mounted. Geopolitical tensions escalated in the Middle East. Oil prices reacted. Earnings reports delivered mixed re... |
| 16.07.2026 | Doc Parghi Assumes Role as Board Chair for Ben Franklin Technology Partners of Southeastern Pennsylvania | PHILADELPHIA – Ben Franklin Technology Partners of Southeastern Pennsylvania (Ben Franklin) announced Doc Parghi as the organization’s new Chair of its Board of Directors, effective July 1, 2026.
Parghi assumes the role formerly occupied by... |
| 16.07.2026 | Protagonist Therapeutics Reports Granting of Inducement Awards | NEWARK, CA / ACCESS Newswire / July 16, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on July 15, 2026, it granted inducement awards to three recently hired employees in accordance with the terms of their employmen... |
| 16.07.2026 |
Jim Cramer likes these 5 non-tech stocks Wall Street got wrong this earnings season | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer said Wall Street unfairly punished several companies despite delivering strong earnings.
He highlighted GE Aerospace, Wells Fargo, Johnson & Johnson, Levi’s, and UnitedHealth as buyin... |
| 16.07.2026 | UK Clears First Precision Pill for BRCA-Mutated Prostate Cancer: NICE Now Decides | By Keith Benitez
Published: Jul 16 2026, 11:16 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 15.07.2026 | J&J falls despite a beat-and-raise quarter. Why we’re raising our price target anyways | - |
| 15.07.2026 | Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis | HANGZHOU, China and SHANGHAI and BOSTON, July 15, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, toda... |
| 15.07.2026 | Минздрав впервые зарегистрировал препарат по итогам инспекции за рубежом | Минздрав впервые зарегистрировал препарат по итогам инспекции за рубежом Eisai получила регудостоверение, хотя не проводила клинисследований в России
Японская фармкомпания Eisai 1 июля получила регудостоверение на свой новый препарат против... |
| 15.07.2026 | LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio | Executive Chair Mark Crotty to continue guiding long-term strategic direction
PERTH, Australia, July 15, 2026 /PRNewswire/ -- LumaCina, a global supplier and marketer of sterile injectable pharmaceutical products and a Bridgewest Group port... |
| 15.07.2026 | ACROBiosystems Obtains PMDA Material Suitability Confirmation for GMP-grade IL-15, Ensuring Reliable Quality and Strengthening the Biopharmaceutical Approval Process | NEWARK, Del., July 15, 2026 /PRNewswire/ -- Recently, ACROBiosystems has officially received the "Material Suitability Confirmation for Regenerative Medicine Products" (Certificate No.: 薬機審長発第47号) from the Pharmaceuticals and Medi... |
| 14.07.2026 | Stock futures rise as soft inflation reading lifts market: Live updates | Stock futures rose early Wednesday after a rally fueled by softer-than-expected inflation data.
Futures tied to the Dow Jones Industrial Average inched 0.1% higher. S&P 500 futures gained 0.2%, while Nasdaq 100 futures added 0.7%.
Stock... |
| 14.07.2026 | Johnson & Johnson has a chance to show it’s more than just a rotation winner | - |
| 13.07.2026 | 5 Things to Know
Iran strikes, Lindsey Graham, Apple takes OpenAI to court and more in Morning Squawk | This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.
Happy Monday. I spent the weekend on an overnight trail race in Vermont. Even if you stayed home, you likely still felt inflation’s pinch.
St... |
| 13.07.2026 | Cosmeceutical Market Trends: Skincare Innovation and Personalized Beauty Driving Growth | The cosmeceutical market is experiencing strong global growth as consumers increasingly seek skincare and personal care products that combine cosmetic benefits with scientifically backed active ingredients. Cosmeceuticals are formulated wit... |
| 12.07.2026 | Daily Stock Market Live
Stock futures slip after U.S., Iran exchange airstrikes again; Kospi plunges 7%: Live updates | Stock futures fell slightly on Sunday night as traders weighed the latest events in the Middle East and braced for a slew of corporate earnings reports due out later in the week.
Dow Jones Industrial Average futures slipped 135 points, or 0... |
| 10.07.2026 | Global Pulsed Field Ablation Market and Forecast to 2032 | The global pulsed field ablation market was valued at USD 2 billion in 2025 and is projected to reach USD 8.9 billion by 2032, expanding at a CAGR of 23.7% during the forecast period. Pulsed field ablation (PFA) is an advanced non-thermal c... |
| 09.07.2026 | Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo | HANGZHOU, China, SHANGHAI and BOSTON, July 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today an... |
| 09.07.2026 | Immunotherapy Drugs Market to Reach $580.6 Billion by 2029 | The global Immunotherapy drugs market is projected to grow from USD 285.3 billion in 2024 to USD 580.6 billion by 2029, at a robust CAGR of 15.3% during the forecast period. Market growth is driven by advancements in antibody engineering te... |
| 08.07.2026 | J&J Wins FDA Approval for Dual-Energy Ablation Catheter That Solves PFA’s Main Limit | By Maxwell Templeton
Published: Jul 08 2026, 3:15 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 07.07.2026 | EQT to acquire the TachoSil® biosurgery business from Corza Medical | EQT to acquire the TachoSil® biosurgery business from Corza Medical
Tue, Jul 07, 2026 08:00 CET Report this content
EQT to acquire Corza Biosurgery, a premier biosurgery business built around TachoSil, a leading hemostat and sealant patch u... |
| 06.07.2026 | Founder Olive Tai Appointed Chairman of the Board of Synagistics; John Wu Appointed Chief Executive Officer as Company Enters Next Stage of AI and Digital Commerce Growth | HONG KONG, July 6, 2026 /PRNewswire/ -- Synagistics Limited ("Synagistics", Stock code: 2562.HK), a Singapore-based AI, big data and digital commerce company listed on the Main Board of The Stock Exchange of Hong Kong Limited, tod... |
| 06.07.2026 |
Jim Cramer says these are the 5 stocks to buy during this market rotation | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer said investors should use the latest market rotation as an opportunity to buy high-quality companies that were swept lower by broad institutional selling.
He highlighted Johnson & Joh... |
| 01.07.2026 | Protagonist Therapeutics Reports Granting of Inducement Awards | NEWARK, CA / ACCESS Newswire / July 1, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on June 30, 2026, it granted inducement awards to three recently hired employees in accordance with the terms of their employment... |
| 30.06.2026 | Marley Health Launches To Build Clinical Intelligence Platform For Proactive Pet Care | Marley Health announced its launch as a clinical intelligence company applying human healthcare science to pet health.
The company is developing AI-enabled pet-health intelligence designed to support more proactive and data-informed veterin... |
| 29.06.2026 | Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities | Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the FDA’s PreCheck pilot program, CNBC has learned.
The FDA PreCheck program is designed t... |
| 26.06.2026 | RQ Bio Raises $115 Million Series A To Advance Influenza Prevention Antibody Program | RQ Bio announced that it has completed an oversubscribed $115 million Series A financing round. The financing was led by Frazier Life Sciences, with participation from new investors EQT Life Sciences, Forbion, Monograph, and Wellington Mana... |
| 25.06.2026 | Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform | Johnson & Johnson today announced the commercial launch of the Dual Energy THERMOCOOL SMARTTOUCH SF (DE STSF) Platform in Europe, expanding physician access to a dual-energy catheter ablation solution designed for personalized care acro... |
| 25.06.2026 | Daily Stock Market Live
Nasdaq Composite posts fifth losing session Friday as chip stocks tumble: Live updates | The Nasdaq Composite posted its fifth consecutive losing session Friday as investors rotated out of key technology stocks and into more defensive areas of the market.
The tech-heavy index dropped 0.24% to close at 25,297.62, while the S&... |
| 22.06.2026 | Daily Stock Market Live
S&P 500 falls on global chip rout with Nasdaq off 2%, led by Micron: Live updates | The S&P 500 was lower on Tuesday as a tech sell-off that began during the prior session picked up steam overnight, with global markets in Asia routed as memory chip-related shares tumbled.
The broad market index fell 1.3%, while the Nas... |
| 16.06.2026 | Johnson Johnson Myeloma Data Cuts Death Risk 53%: Cure Within Decade Gains Ground | By Richard L. Wells
Published: Jun 16 2026, 22:40 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 16.06.2026 | Colorado receives FDA permission to import cheaper drugs — including Ozempic — from Canada | Getting your Trinity Audio player ready...
Colorado finally has federal permission to start importing cheaper prescription drugs from Canada, but the state may not have any sellers to work with.
Lawmakers passed a bill in 2019 that directed... |
| 15.06.2026 | Johnson & Johnson Raises U.S. Vision Manufacturing Capacity With More Than $1 Billion Jacksonville Investment | Johnson & Johnson announced an investment of more than $1 billion to expand its Vision operations in Jacksonville, Florida, strengthening the company’s U.S.-based manufacturing, packaging, and distribution capabilities for its ACUVUE-br... |
| 15.06.2026 | Salesforce looks to strengthen its AI platform — plus, a positive note for J&J | - |
| 13.06.2026 | ThruFlo Endovascular Secures Seed Funding To Advance Bifurcation Aneurysm Treatment Platform | ThruFlo Endovascular announced the completion of a seed financing round led by Atlas MedInnovation to accelerate development of its bifurcated flow diverter platform designed specifically for bifurcation aneurysms. The funding will support ... |
| 13.06.2026 | Switzerland is voting on whether to cap its population at 10 million. Here’s what to know | Switzerland will hold a referendum on Sunday on whether to cap its population at 10 million people.
If the measure is passed, Swiss officials will have to roll out measures to curb population growth until 2050.
Businesses have warned that l... |
| 10.06.2026 | Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor | HANGZHOU, China, SHANGHAI and BOSTON, June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, tod... |
| 08.06.2026 | KRAS Cancer Treatment: J&J Acquires Firefly Bio for $1B to Destroy, Not Block, Tumor Protein | By Chase Fiorini
Published: Jun 08 2026, 15:49 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 08.06.2026 | Американская Johnson & Johnson покупает Firefly Bio за $1 млрд для разработки новых противораковых препаратов | Платформа Firefly под названием Firelink использует антитела для доставки препарата, разрушающего белки, непосредственно в раковые клетки. В J&J отмечают, что такой подход может позволить воздействовать на опухоли более прицельно, снижа... |
| 05.06.2026 | Narayana Health City Performs India's First Pulsed Field Ablation for Advanced Treatment of Atrial Fibrillation | Bengaluru, Karnataka, India
Narayana Health City has announced the achievement of a significant milestone in Cardiac Electrophysiology by performing India’s first Pulsed Field Ablation (PFA) for the treatment of Atrial Fibrillation (AFib), ... |
| 04.06.2026 | New medical guidance affirms Tylenol safety during pregnancy months after Trump sows doubt | Getting your Trinity Audio player ready...
By Sofia Resnick, Stateline.org
The Society for Maternal-Fetal Medicine published new clinical guidance this week affirming that acetaminophen, better known by its brand Tylenol, should be the “fir... |
| 03.06.2026 | Global enterprises join Talogy to rethink High Potential talent at SIOP Conference 2026 | Research paper on GenAI use another key highlight during four-day event
PITTSBURGH, June 3, 2026 /PRNewswire/ -- Global talent management solutions specialist, Talogy, delivered a landmark session designed to rewrite the rules for high-pote... |
| 02.06.2026 | Rhythm AI Appoints Medtech Veteran Mike Dineen as Chief Executive Officer | , a MedTech company focused on optimizing atrial fibrillation (AF) procedures and developer of the STAR Apollo™ Mapping Software, announced the appointment of Mike Dineen as Chief Executive Officer. Dineen brings more than 30 years of medte... |
| 02.06.2026 | 4 Critical Guardrails for Community Hospital Tech Procurement | Jian Zhang, founder & CEO of Noah Medical
Healthcare is moving toward models that reward outcomes, continuity, and population health management, yet disparities in access to specialized care continue to persist. And while community hosp... |
| 01.06.2026 | Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment's Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczema | HANGZHOU, China, SHANGHAI and BOSTON, June 1, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today an... |
| 28.05.2026 | Fluidra Appoints Juan Graham as Chief Financial Officer | Fluidra (MAD:FDR), the global leader in equipment and connected solutions in the pool and wellness sector, today announced that its Board of Directors has appointed Juan Graham as Chief Financial Officer.
Graham will join the company and Fl... |
| 28.05.2026 | Metis MedTech: John Slump Launches Medtech Investment And Advisory Platform Following Atraverse Medical Exit | John Slump, the co-founder and former president and CEO of Atraverse Medical, announced the launch of Metis MedTech, a new investment and strategic advisory platform focused on helping medical device founders build, fund, and scale their co... |
| 27.05.2026 | CGBIO Signs Global Clinical and Exclusive Commercialization Agreement for NOVOSIS in the U.S., Canada and Australia | DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development and regulatory approvals, including FDA IDE and PMA pathways
Full-scale entry into Nor... |
| 22.05.2026 | Ken Paxton Wanted To Crack Down On Forum Shopping. Now Lawyers Say He’s Improperly Seeking Out Favorable Courts. | This story was originally published by ProPublica. Republished under a CC BY-NC-ND 3.0 license.
In October, Texas Attorney General Ken Paxton sued pharmaceutical companies tied to Tylenol in state court, repeating claims made a month earlie... |
| 21.05.2026 | Bulletin from Moberg Pharma’s AGM on May 21[st], 2026 | Bulletin from Moberg Pharma’s AGM on May 21[st], 2026
Thu, May 21, 2026 15:00 CET Report this content
STOCKHOLM, May 21, 2026. Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") held its Annual General Meeting to... |
| 18.05.2026 | Johnson & Johnson Launches 'Gut Tunnel' Experience in Singapore to Highlight the Importance of Endoscopic Remission in IBD | New data presented at Digestive Disease Week 2026 reinforces endoscopic remission as being associated with long-term patient outcomes,[1],[2] yet more than 60% of people with IBD have not heard of this key treatment goal.[3],[4]
Anchoring W... |
| 18.05.2026 | Two-Time Cancer Patient Embarks on 540-Kilometer Lycian Way Challenge to Fund Rural Cancer Screening | A two-time cancer survivor is trekking 540km across Türkiye to fund rural cancer screenings and support Movember.
CHARLESTON, S.C., May 18, 2026 /PRNewswire-PRWeb/ -- Jason Cronen's cancer journey began in 2004 with a devastating Stage Thre... |
| 16.05.2026 | Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever | - |
| 13.05.2026 | Isomorphic Labs Secures $2.1 Billion for AI Drug Discovery Global Scale | Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital injection accelerates its world-leading AI drug design engine, IsoDDE. The company expands globally, fast-tracking its therapeutic pipeline. Isomorphic aims to... |
| 13.05.2026 | DeepMind CEO Demis Hassabisâ Isomorphic Labs raises $2.1 billion led by Thrive Capital | Synopsis
AI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of their AI drug design engine and advance therapeutic candidates. The investment underscores st... |
| 13.05.2026 | Isomorphic Labs Raises $2.1 Billion Series B To Scale AI Drug Design Engine And Advance Therapeutic Pipeline | Isomorphic Labs, the London-based AI-first drug design and development company, has raised $2.1 billion in Series B funding to accelerate its evolution from pioneering novel AI models to applying them at scale. The round is led by Thrive Ca... |
| 13.05.2026 | Here are Wednesday’s biggest analyst calls: Nvidia, Apple, Micron, Amazon, AMD, Johnson & Johnson & more | - |
| 12.05.2026 | The Future of Surgical Robotics: Exploring Advanced Supply Chains and Manufacturing at 2026 Medtec | SHANGHAI, May 12, 2026 /PRNewswire/ -- In 2026, the surgical robotics industry continues to grow steadily. Recent reports show that both procedure volumes and system deployments are rising consistently. Intuitive Surgical surpassed expectat... |
| 12.05.2026 | Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine | Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.
LONDON, May 12, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and d... |
| 10.05.2026 | ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D | NEWARK, Del., May 10, 2026 /PRNewswire/ -- ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrative process to a streamlined, purchase-bas... |
| 09.05.2026 | Googleâs Isomorphic Labs to raise over $2 billion in new funding | Synopsis
Alphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. This significant investment aims to bolster its drug design engine and fuel global expansion... |
| 07.05.2026 | Global drugmakers eye more China biotech deals after record year | Global pharmaceutical executives are hungry for more deals with Chinese biotechnology companies after a record year, even as a stock market boom shows signs of cooling down.
2025 was a breakout year for China’s biopharma industry. Out-licen... |